Vanda Pharmaceuticals Inc. Quarterly Current Ratio in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Vanda Pharmaceuticals Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q3 2024.
  • Vanda Pharmaceuticals Inc. Current Ratio for the quarter ending September 30, 2024 was 479 %, a 19.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 479 -115 -19.3% Sep 30, 2024
Q2 2024 514 -59.4 -10.4% Jun 30, 2024
Q1 2024 550 -11.8 -2.1% Mar 31, 2024
Q4 2023 576 +20.9 +3.76% Dec 31, 2023
Q3 2023 594 +23.6 +4.13% Sep 30, 2023
Q2 2023 573 -19.4 -3.28% Jun 30, 2023
Q1 2023 562 -46.2 -7.6% Mar 31, 2023
Q4 2022 555 -90.3 -14% Dec 31, 2022
Q3 2022 570 -69.6 -10.9% Sep 30, 2022
Q2 2022 593 -45.8 -7.17% Jun 30, 2022
Q1 2022 608 -30.8 -4.82% Mar 31, 2022
Q4 2021 645 +24.5 +3.94% Dec 31, 2021
Q3 2021 640 +25.4 +4.13% Sep 30, 2021
Q2 2021 638 +65.9 +11.5% Jun 30, 2021
Q1 2021 639 +95.4 +17.6% Mar 31, 2021
Q4 2020 621 +100 +19.3% Dec 31, 2020
Q3 2020 615 +103 +20.1% Sep 30, 2020
Q2 2020 572 +29.7 +5.46% Jun 30, 2020
Q1 2020 543 -18.4 -3.28% Mar 31, 2020
Q4 2019 521 +2.7 +0.52% Dec 31, 2019
Q3 2019 512 +86.7 +20.4% Sep 30, 2019
Q2 2019 543 +201 +58.8% Jun 30, 2019
Q1 2019 562 +286 +104% Mar 31, 2019
Q4 2018 518 +283 +120% Dec 31, 2018
Q3 2018 425 +171 +67.1% Sep 30, 2018
Q2 2018 342 +66 +23.9% Jun 30, 2018
Q1 2018 275 -23 -7.71% Mar 31, 2018
Q4 2017 235 -86 -26.8% Dec 31, 2017
Q3 2017 254 -61.8 -19.5% Sep 30, 2017
Q2 2017 276 -49.4 -15.2% Jun 30, 2017
Q1 2017 298 -44.6 -13% Mar 31, 2017
Q4 2016 321 -67.5 -17.4% Dec 31, 2016
Q3 2016 316 -183 -36.7% Sep 30, 2016
Q2 2016 325 -114 -26% Jun 30, 2016
Q1 2016 343 -33.9 -9% Mar 31, 2016
Q4 2015 389 +94.5 +32.1% Dec 31, 2015
Q3 2015 499 +256 +106% Sep 30, 2015
Q2 2015 439 +130 +42% Jun 30, 2015
Q1 2015 377 +27.5 +7.87% Mar 31, 2015
Q4 2014 294 -100 -25.4% Dec 31, 2014
Q3 2014 243 -146 -37.5% Sep 30, 2014
Q2 2014 309 -65.4 -17.4% Jun 30, 2014
Q1 2014 349 -49.7 -12.5% Mar 31, 2014
Q4 2013 394 -36.7 -8.52% Dec 31, 2013
Q3 2013 388 -65.2 -14.4% Sep 30, 2013
Q2 2013 375 -101 -21.2% Jun 30, 2013
Q1 2013 399 -114 -22.2% Mar 31, 2013
Q4 2012 431 Dec 31, 2012
Q3 2012 454 Sep 30, 2012
Q2 2012 476 Jun 30, 2012
Q1 2012 513 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.